These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29708744)

  • 21. Investigation of the structural requirements for N-methyl-D-aspartate receptor positive and negative allosteric modulators based on 2-naphthoic acid.
    Irvine MW; Fang G; Sapkota K; Burnell ES; Volianskis A; Costa BM; Culley G; Collingridge GL; Monaghan DT; Jane DE
    Eur J Med Chem; 2019 Feb; 164():471-498. PubMed ID: 30622023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of recombinant GluN1/GluN2A and GluN1/GluN2B N-methyl-D-aspartate receptors by single malt whiskies.
    Otton HJ; Janssen A; Wyllie DJ
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1423-5. PubMed ID: 19909290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subtype-dependence of N-methyl-D-aspartate receptor modulation by pregnenolone sulfate.
    Horak M; Vlcek K; Chodounska H; Vyklicky L
    Neuroscience; 2006; 137(1):93-102. PubMed ID: 16257494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity relationships for allosteric NMDA receptor inhibitors based on 2-naphthoic acid.
    Costa BM; Irvine MW; Fang G; Eaves RJ; Mayo-Martin MB; Laube B; Jane DE; Monaghan DT
    Neuropharmacology; 2012 Mar; 62(4):1730-6. PubMed ID: 22155206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of rat recombinant GluN1/GluN2A and GluN1/GluN2B NMDA receptors by ethanol at concentrations based on the US/UK drink-drive limit.
    Otton HJ; Janssen A; O'Leary T; Chen PE; Wyllie DJ
    Eur J Pharmacol; 2009 Jul; 614(1-3):14-21. PubMed ID: 19394328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional evidence for a twisted conformation of the NMDA receptor GluN2A subunit N-terminal domain.
    Stroebel D; Carvalho S; Paoletti P
    Neuropharmacology; 2011 Jan; 60(1):151-8. PubMed ID: 20621105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isoform-specific Inhibition of N-methyl-D-aspartate Receptors by Bile Salts.
    Koch A; Bonus M; Gohlke H; Klöcker N
    Sci Rep; 2019 Jul; 9(1):10068. PubMed ID: 31296930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temperature dependence of N-methyl-D-aspartate receptor channels and N-methyl-D-aspartate receptor excitatory postsynaptic currents.
    Korinek M; Sedlacek M; Cais O; Dittert I; Vyklicky L
    Neuroscience; 2010 Feb; 165(3):736-48. PubMed ID: 19883737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Properties of Triheteromeric
    Yi F; Zachariassen LG; Dorsett KN; Hansen KB
    Mol Pharmacol; 2018 May; 93(5):453-467. PubMed ID: 29483146
    [No Abstract]   [Full Text] [Related]  

  • 30. High sensitivity of cerebellar neurons to homocysteine is determined by expression of GluN2C and GluN2D subunits of NMDA receptors.
    Sibarov DA; Giniatullin R; Antonov SM
    Biochem Biophys Res Commun; 2018 Nov; 506(3):648-652. PubMed ID: 30454701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of novel GluN2A NMDAR positive allosteric modulators via scaffold hopping strategy as anti-stroke therapeutic agents.
    Chen X; Zhu H; Liu X; Li Q; Dong M
    Bioorg Med Chem; 2023 Apr; 83():117236. PubMed ID: 36934527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synaptic NMDA receptors in basolateral amygdala principal neurons are triheteromeric proteins: physiological role of GluN2B subunits.
    Delaney AJ; Sedlak PL; Autuori E; Power JM; Sah P
    J Neurophysiol; 2013 Mar; 109(5):1391-402. PubMed ID: 23221411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The glutamate receptor GluN2 subunit regulates synaptic trafficking of AMPA receptors in the neonatal mouse brain.
    Hamada S; Ogawa I; Yamasaki M; Kiyama Y; Kassai H; Watabe AM; Nakao K; Aiba A; Watanabe M; Manabe T
    Eur J Neurosci; 2014 Oct; 40(8):3136-46. PubMed ID: 25131300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New advances in NMDA receptor pharmacology.
    Ogden KK; Traynelis SF
    Trends Pharmacol Sci; 2011 Dec; 32(12):726-33. PubMed ID: 21996280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 7-Methoxyderivative of tacrine is a 'foot-in-the-door' open-channel blocker of GluN1/GluN2 and GluN1/GluN3 NMDA receptors with neuroprotective activity in vivo.
    Kaniakova M; Kleteckova L; Lichnerova K; Holubova K; Skrenkova K; Korinek M; Krusek J; Smejkalova T; Korabecny J; Vales K; Soukup O; Horak M
    Neuropharmacology; 2018 Sep; 140():217-232. PubMed ID: 30099049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allosteric Interactions between NMDA Receptor Subunits Shape the Developmental Shift in Channel Properties.
    Sun W; Hansen KB; Jahr CE
    Neuron; 2017 Apr; 94(1):58-64.e3. PubMed ID: 28384476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple effects of copper on NMDA receptor currents.
    Marchetti C; Baranowska-Bosiacka I; Gavazzo P
    Brain Res; 2014 Jan; 1542():20-31. PubMed ID: 24161827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of AICP as a GluN2C-Selective
    Jessen M; Frederiksen K; Yi F; Clausen RP; Hansen KB; Bräuner-Osborne H; Kilburn P; Damholt A
    Mol Pharmacol; 2017 Aug; 92(2):151-161. PubMed ID: 28588066
    [No Abstract]   [Full Text] [Related]  

  • 39. Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders.
    Tang W; Liu D; Traynelis SF; Yuan H
    Neuropharmacology; 2020 Oct; 177():108247. PubMed ID: 32712275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GluN2B-containing NMDA receptors as possible targets for the neuroprotective and antidepressant effects of fluoxetine.
    Kiss JP; Szasz BK; Fodor L; Mike A; Lenkey N; Kurkó D; Nagy J; Vizi ES
    Neurochem Int; 2012 Jan; 60(2):170-6. PubMed ID: 22197911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.